Allscripts Healthcare Solutions, Inc.’s (MDRX - Free Report) Sunrise EHR (Electronic Health Record) platform was recently selected by U.K.-based Maidstone and Tunbridge Wells NHS Trust.
Per management, the latest development solidifies the company’s position in the South East of England apart from strengthening the trust’s relationship with Allscripts.
In 2015, East Kent Hospitals University NHS Foundation Trust and Maidstone and Tunbridge Wells NHS Trust of the United Kingdom deployed Allscripts PAS (Patient Administration System). Notably, PAS is a suite of products that was developed specifically for the U.K. healthcare sector.
Coming back to the news, the trust, which already uses Allscripts PAS, will roll out the Sunrise clinical suite to focus on improving patient outcome.
In the recently reported second quarter, Allscripts released a new version of Allscripts PM (Practice Management) — a comprehensive revenue cycle management solution.
Per MarketsandMarkets, the global EHR market is projected to reach a value of $1,403.2 million by 2021, at a CAGR of 20.8%. Government initiatives and incentive programs along with increasing focus on reducing medical errors keep the market going strong.
Hence, Allscripts’ latest move can be assessed as a timely and strategic one.
More on Sunrise
Allscripts Sunrise is a fully integrated platform that connects all clinical and financial aspects of a hospital or health system for inpatient, emergency and outpatient care.
In the recently reported second quarter, Allscripts signed a five-year deal with Clark Memorial Hospital to extend their business with the addition of Sunrise Surgical and Anesthesia modules.
Allscripts’ Sunrise clinicals will also be implemented by the Singapore Ministry of Health later in 2018 at the 14,000-bed SengKang General and Community Hospitals system.
In the past year, shares of Allscripts have rallied 9.6% compared with the industry’s rise of 13.2%.
We believe that developments such as these will provide cushion to the stock.
Zacks Rank & Key Picks
Allscripts carries a Zacks Rank #3 (Hold).
A few better-ranked stocks in the broader medical space are Intuitive Surgical (ISRG - Free Report) , athenahealth (ATHN - Free Report) and Integer Holdings Corporation (ITGR - Free Report) .
Intuitive Surgical’s expected long-term earnings growth rate is 14.7%. The stock carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
athenahealth has a long-term projected earnings growth rate of 17.6%. The stock flaunts a Zacks Rank #1 (Strong Buy).
Integer Holdings’ long-term expected earnings growth rate is 15%. The stock sports a Zacks Rank #1.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>